Theravance Biopharma Inc Cash Flow Quality Index
Theravance Biopharma Inc cash flow quality index. Theravance Biopharma Inc (0TB) has a Cash Flow Quality Index of -1.80x as of September 2025. Operating cash flow of €-6.51 Million is below net income of €3.62 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Theravance Biopharma Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Theravance Biopharma Inc (2022–2022)
Cash flow quality index of Theravance Biopharma Inc from 2022 to 2022. Historical Cash Flow Quality Index for Theravance Biopharma Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Theravance Biopharma Inc (0TB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Theravance Biopharma Inc Cash Flow Quality Index by Year (2022–2022)
Theravance Biopharma Inc cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for Theravance Biopharma Inc. For the full cash flow conversion analysis, see Theravance Biopharma Inc cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.21x | €-186.99 Million | €872.13 Million | — |